关键词: ACT OCD acceptance and commitment therapy obsessive–compulsive disorder randomized control trial review

Mesh : Obsessive-Compulsive Disorder / therapy Humans Iran Acceptance and Commitment Therapy Randomized Controlled Trials as Topic Selective Serotonin Reuptake Inhibitors / therapeutic use

来  源:   DOI:10.1891/JCP-2023-0009

Abstract:
Acceptance and commitment therapy (ACT) for obsessive-compulsive disorder (OCD) has been found efficacious in randomized clinical trials (RCTs), but the two widely known RCTs were conducted within the United States with predominantly White samples. Research that evaluates treatments like ACT for OCD outside the typical Western cultures is needed. The current scoping review summarizes the key characteristics and findings from 18 RCTs that evaluated ACT for OCD in Iran. These RCTs are largely unknown in the broader scientific literature despite representing the vast majority of ACT for OCD trials, in part because the majority are published in Persian. The preponderance of RCTs treated participants in groups, and most protocols did not include exposure exercises. Of 18 trials, 5 were single sex. Use of selective serotonin reuptake inhibitors (SSRIs) was common with all participants on stable doses at pretreatment in many of the trials. Methodological quality was low to medium. ACT was inconsistent against nontraditional comparison conditions, slightly favorable to empirically validated treatments, and favorable compared with the waitlist and SSRIs. The process of change data indicated that ACT increased the psychological flexibility more than cognitive behavior therapy or SSRIs. These results highlight that findings on ACT for OCD from Western populations replicate and generalize to individuals in Iran. These findings also offer insights gained from studying ACT in Iran and significantly expand the literature based on ACT for OCD that can be integrated into scholarship by all researchers.
摘要:
在随机临床试验(RCT)中发现强迫症(OCD)的接受和承诺疗法(ACT)有效,但这两个广为人知的RCT是在美国境内进行的,主要是白色样本。需要研究评估典型西方文化之外的强迫症治疗方法,如ACT。当前的范围审查总结了18个RCT的主要特征和发现,这些RCT评估了伊朗的ACT强迫症。这些RCT在更广泛的科学文献中基本上是未知的,尽管代表了强迫症试验的绝大多数ACT,部分原因是大多数是以波斯语出版的。RCT的优势是分组治疗的参与者,大多数方案不包括暴露练习。在18次试验中,5是单身。在许多试验中,使用选择性5-羟色胺再摄取抑制剂(SSRIs)在治疗前稳定剂量的所有参与者中都很常见。方法学质量低到中等。ACT与非传统比较条件不一致,稍微有利于经验验证的治疗方法,与等候名单和SSRI相比,也是有利的。变化过程数据表明,ACT比认知行为疗法或SSRIs更增加了心理灵活性。这些结果突出表明,来自西方人群的ACT强迫症的发现可以复制并推广到伊朗的个人。这些发现还提供了在伊朗研究ACT所获得的见解,并大大扩展了基于ACT的OCD文献,这些文献可以被所有研究人员纳入奖学金。
公众号